|
 |
 Home > Available Issues |
|
|
 Special Article |
| Clinical Practice Guideline for Antiviral Treatment and Chemoprophylaxis of Seasonal Influenza |
| Clinical Practice Guideline for Antiviral Treatment and Chemoprophylaxis of Seasonal Influenza Won-Suk Choi1, Jacob Lee2, Hee-Young Lee3, Ji-Hyeon Baek4, Yun-Kyung Kim5, Sae-Yoon Kee6, Hye-Won Jeong7, Young-Keun Kim8, Joon-Young Song1, Seong-Heon Wie9 and Jin-Soo Lee4; Transgovernmental Enterprise for Pandemic Influenza in Korea |
| 1Department of Internal Medicine, Korea University College of Medicine, Seoul; 2Department of Internal Medicine, Hallym University College of Medicine, Seoul; 3Gachon University Gil Hospital Cancer Center, Incheon; 4Department of Internal Medicine, Inha University College of Medicine, Incheon; 5Department of Pediatrics, Korea University College of Medicine, Ansan; 6Department of Internal Medicine, Konkuk University College of Medicine, Chungju; 7Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju; 8Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju; 9Department of Internal Medicine, Catholic University College of Medicine, Suwon, Korea |
Vol.44 Num.4 (p233~249)
|
|
|
|
Influenza, a highly communicable disease, causes variable epidemics annually and imposes public health problems and socioeconomic burden. In addition to vaccine, antiviral medication has an important role in treatment and prevention of influenza virus infection. As influenza virus is undergoing change of antigenicity and antiviral susceptibility, proper use of antiviral medication is important. This guideline encompasses treatment and chemoprophylaxis with antiviral medications for seasonal influenza based on the current influenza situation in Korea. These recommendations were intended for physicians in all medical specialties who provide care for influenza patients. |
|
|
Keywords : Influenza, Guideline, Treatment, Chemoprophylaxis, Antiviral agents |
|
|
|
|
|
|
|
|
